Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...

Greetings, and welcome to the ASGN Incorporated first-quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today announced a Trials in Progress ...

EY US has teamed up with Confluent to help organizations harness the power of real-time data streaming through a complete platform built on Apach ...